Jan 2013 to Dec 2017 | Jan 2017 to Dec 2017
CHARGE CAPTURE ANALYSIS FOR DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) GROUP BASED ON MEDICARE | Back to Top |
| DRG Code | DRG Description | Category | Sub Category | DRG Group | Surgical Category | Case Mix Level | Total National Projected Hospitalizations - Annualized | Total Medicare Hospitalizations - Jan 2017 to Dec 2017 | Total Medicare Hospitalizations - Jan 2013 to Dec 2017 | Total Medicare Hospitalizations After Exclusion | Avg. LOS | GMLOS | All Cause Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment per Day | Payment per Discharge | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 846 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Non Surgical | 17.00 | NA | 3,899 | 17,084 | 16,264 | ||||||||||||
| 848 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Non Surgical | 2.80 | NA | 378 | 2,814 | 2,806 | ||||||||||||
| 847 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Non Surgical | 80.20 | NA | 15,246 | 80,577 | 80,313 |
DEMOGRAPHIC DETAILS OF DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| Race | Total Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|
| White | 13,318 | 77.96 |
| Black | 2,161 | 12.65 |
| Hispanic | 466 | 2.73 |
| Age Group ( Years ) | Total Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|
| 65 to 69 | 5,071 | 29.68 |
| Less than 65 | 4,285 | 25.08 |
| 70 to 74 | 3,832 | 22.43 |
TOP ICD DIAGNOSIS CODES FOR DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| ICD Code | ICD Description | Total ICD & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|
| V5811 | Encounter for antineoplastic chemotherapy | 8,551 | 50.05 |
| Z5111 | Encounter for antineoplastic chemotherapy | 8,289 | 48.52 |
| 4019 | Unspecified essential hypertension | 3,484 | 20.39 |
TOP ICD PROCEDURE CODES FOR DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| ICD Code | ICD Description | Total Procedure ICD & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|
| 9925 | Injection Or Infusion Of Cancer Chemotherapeutic Substance | 8,149 | 47.7 |
| 3E04305 | Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach | 3,763 | 22.03 |
| 3E03305 | Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach | 2,719 | 15.92 |
TOP HOSPITALS ASSOCIATED WITH DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| Hospital Name | Address | City | State | Zip Code | Total Hospital & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| University of Texas MD Anderson Cancer Center | 1515 HOLCOMBE BLVD | Houston | TX | 77030 | 450 | 2.63 |
| The University of Chicago Medical Center | 5841 S. MARYLAND AVE | Chicago | IL | 60637 | 338 | 1.98 |
| UCSF Medical Center | 505 PARNASSUS AVE | San Francisco | CA | 94143 | 315 | 1.84 |
TOP ATTENDING PHYSICIAN ASSOCIATED WITH DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| Physician Name | Address | City | State | Zip Code | Total Physician & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| DR. VIKAS BHUSHAN | 7777 FOREST LN | DALLAS | TX | 75230 | 82 | 0.48 |
| DR. MIGUEL CEREJO | 400 TAYLOR BLVD | PLEASANT HILL | CA | 94523 | 56 | 0.33 |
| DR. TATYANA A FELDMAN | 92 2ND ST | HACKENSACK | NJ | 07601 | 55 | 0.32 |
TOP OPERATING PHYSICIAN ASSOCIATED WITH DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| Physician Name | Address | City | State | Zip Code | Total Physician & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| DR. DANIEL J HARAF | 5841 S MARYLAND AVE # MC1099 | CHICAGO | IL | 60637 | 109 | 0.64 |
| DR. VIKAS BHUSHAN | 7777 FOREST LN | DALLAS | TX | 75230 | 58 | 0.34 |
| DR. MIGUEL CEREJO | 400 TAYLOR BLVD | PLEASANT HILL | CA | 94523 | 54 | 0.32 |
DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) SUMMARY TABLE | Back to Top |
| Category | Sub Category | DRG Group | ICD Codes | ICD Description | National Projected Hospitalizations (Present on Admission - All) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - All) Jan 2013 to Dec 2017 | National Projected Hospitalizations(Present on Admission - Yes) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - Yes) Jan 2013 to Dec 2017 | National Projected Hospitalizations (Present on Admission - Not Y) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - Not Y) Jan 2013 to Dec 2017 | Total Discharges After Exclusion | Avg. LOS | GMLOS | All Cause Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment per Day | Payment per Discharge | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | V5811 | Encounter for antineoplastic chemotherapy | NA | 8,551 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Z5111 | Encounter for antineoplastic chemotherapy | 15,635 | 8,289 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | I10 | Essential (primary) hypertension | 4,500 | 3,540 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | 4019 | Unspecified essential hypertension | NA | 3,484 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | T451X5A | Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter | 7,012 | 3,316 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | D61810 | Antineoplastic chemotherapy induced pancytopenia | 6,341 | 3,108 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | 28411 | Antineoplastic chemotherapy induced pancytopenia | NA | 2,861 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | E785 | Hyperlipidemia, unspecified | 2,010 | 2,415 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Z87891 | Personal history of nicotine dependence | 2,545 | 2,383 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | 2724 | Other and unspecified hyperlipidemia | NA | 2,157 |